{"id":2282,"date":"2023-07-04T08:09:00","date_gmt":"2023-07-04T08:09:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=2282"},"modified":"2023-07-05T08:09:37","modified_gmt":"2023-07-05T08:09:37","slug":"first-ai-generated-drug-given-go-ahead-for-human-trials","status":"publish","type":"post","link":"https:\/\/dailyai.com\/fr\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","title":{"rendered":"Le premier m\u00e9dicament g\u00e9n\u00e9r\u00e9 par l'IA re\u00e7oit le feu vert pour des essais sur l'homme"},"content":{"rendered":"<p><strong>Insilico Medicine a re\u00e7u l'autorisation de proc\u00e9der \u00e0 des essais sur l'homme de son m\u00e9dicament enti\u00e8rement g\u00e9n\u00e9r\u00e9 par l'IA.<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Ce m\u00e9dicament a \u00e9t\u00e9 con\u00e7u comme un traitement potentiel de la fibrose pulmonaire idiopathique (FPI), une maladie d\u00e9g\u00e9n\u00e9rative qui provoque la cicatrisation et l'\u00e9paississement des tissus pulmonaires. La FPI touche environ 100 000 personnes rien qu'aux \u00c9tats-Unis. Le nouveau m\u00e9dicament, appel\u00e9 INS018_055, sera test\u00e9 pendant 12 semaines en Chine et des essais \u00e9largis sont pr\u00e9vus en Chine et aux \u00c9tats-Unis.<\/span><\/p>\n<p><a href=\"https:\/\/insilico.com\/\"><span style=\"font-weight: 400;\">Insilico<\/span><\/a><span style=\"font-weight: 400;\"> est une soci\u00e9t\u00e9 de biotechnologie bas\u00e9e \u00e0 Hong Kong qui utilise l'IA pour d\u00e9velopper de nouveaux m\u00e9dicaments ainsi que pour la recherche anti-\u00e2ge. L'application de l'IA \u00e0 ses recherches a permis d'acc\u00e9l\u00e9rer consid\u00e9rablement le d\u00e9veloppement de nouveaux m\u00e9dicaments.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">L'IA nous permet d'analyser des quantit\u00e9s massives de donn\u00e9es et de trouver des connexions que les scientifiques humains pourraient manquer, puis d'\"imaginer\" des mol\u00e9cules enti\u00e8rement nouvelles qui peuvent \u00eatre transform\u00e9es en m\u00e9dicaments\", a d\u00e9clar\u00e9 Alex Zhavoronkov, fondateur et PDG d'Insilico Medicine.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">L'entreprise utilise l'IA \u00e0 chaque \u00e9tape de sa strat\u00e9gie de d\u00e9veloppement de m\u00e9dicaments. Elle utilise d'abord son outil aliment\u00e9 par l'IA, appel\u00e9 PandaOmics, pour identifier une \"cible\" ou une cause biologique li\u00e9e \u00e0 une maladie sp\u00e9cifique. Par exemple, la cible peut \u00eatre un g\u00e8ne ou une prot\u00e9ine qui ne fonctionne pas correctement.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Une fois qu'ils ont identifi\u00e9 une cible, ils utilisent leur autre plateforme d'IA, Chemistry42, pour concevoir une mol\u00e9cule qui corrigera le probl\u00e8me en bloquant la cible sans nuire au patient.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dans ce cas, le \"55\" dans le nom du m\u00e9dicament fait r\u00e9f\u00e9rence \u00e0 la 55e mol\u00e9cule qui a \u00e9t\u00e9 con\u00e7ue et qui s'est r\u00e9v\u00e9l\u00e9e prometteuse.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Les essais de phase II qui ont \u00e9t\u00e9 approuv\u00e9s visent \u00e0 d\u00e9terminer si le m\u00e9dicament produit une r\u00e9ponse significative chez les premiers participants. En cas de succ\u00e8s, il passera ensuite aux essais de phase III pour confirmer son innocuit\u00e9 et son efficacit\u00e9 avant que la FDA ne l'approuve.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Insilico Medicine a mis au point un certain nombre de m\u00e9dicaments IA int\u00e9ressants. La FDA a r\u00e9cemment approuv\u00e9 la demande initiale de drogue nouvelle de recherche (IND) pour leur m\u00e9dicament anticanc\u00e9reux qui cible les tumeurs solides. Les essais de phase I sont pr\u00e9vus pour juillet 2023 aux \u00c9tats-Unis et en Chine.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Lorsque nous entendons parler d'IA g\u00e9n\u00e9rative, nous pensons g\u00e9n\u00e9ralement \u00e0 des images, des chansons ou des textes g\u00e9n\u00e9r\u00e9s. Mais Insilico utilise l'IA g\u00e9n\u00e9rative pour identifier les cibles \u00e0 l'origine d'une maladie et concevoir ensuite des mol\u00e9cules qui s'attaquent directement \u00e0 ces cibles.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Si vous demandez \u00e0 ChatGPT quelles prot\u00e9ines pourraient \u00eatre cibl\u00e9es pour traiter un type sp\u00e9cifique de cancer du sein, il pourra les identifier parce qu'il a acc\u00e8s \u00e0 la recherche m\u00e9dicale publi\u00e9e. Insilico dispose de son propre LLM, appel\u00e9 ChatPandaGPT, qui permet aux chercheurs d'utiliser des requ\u00eates en langage naturel pour passer au crible une base de connaissances sp\u00e9cialis\u00e9e contenant de grandes quantit\u00e9s de donn\u00e9es cliniques.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">L'utilisation <\/span><a href=\"https:\/\/dailyai.com\/fr\/2023\/06\/researchers-create-high-performance-ai-model-to-detect-heart-disease-from-ecgs\/\"><span style=\"font-weight: 400;\">L'IA dans la m\u00e9decine<\/span><\/a><span style=\"font-weight: 400;\"> aide des entreprises comme Insilico \u00e0 raccourcir consid\u00e9rablement le processus de d\u00e9couverte de m\u00e9dicaments. Les <\/span><a href=\"https:\/\/insilico.com\/pipeline\"><span style=\"font-weight: 400;\">pipeline de recherche<\/span><\/a><span style=\"font-weight: 400;\"> dispose d'une gamme passionnante de traitements potentiels pour diff\u00e9rents types de cancer, ainsi que d'un m\u00e9dicament COVID-19 qui fait \u00e9galement l'objet d'essais de phase I.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Insilico Medicine a re\u00e7u l'autorisation de proc\u00e9der \u00e0 des essais sur l'homme de son m\u00e9dicament enti\u00e8rement g\u00e9n\u00e9r\u00e9 par l'IA. Ce m\u00e9dicament a \u00e9t\u00e9 con\u00e7u comme un traitement potentiel de la fibrose pulmonaire idiopathique (FPI), une maladie d\u00e9g\u00e9n\u00e9rative qui provoque la cicatrisation et l'\u00e9paississement des tissus pulmonaires. La FPI touche environ 100 000 personnes rien qu'aux \u00c9tats-Unis. Le nouveau m\u00e9dicament, appel\u00e9 INS018_055, sera test\u00e9 pendant 12 semaines en Chine et des essais \u00e9largis sont pr\u00e9vus en Chine et aux \u00c9tats-Unis. Insilico est une soci\u00e9t\u00e9 de biotechnologie bas\u00e9e \u00e0 Hong Kong qui utilise l'IA pour d\u00e9velopper de nouveaux m\u00e9dicaments ainsi que pour la recherche anti-\u00e2ge. L'application de l'IA dans leur<\/p>","protected":false},"author":6,"featured_media":2283,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84],"tags":[150,107,101],"class_list":["post-2282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-ai-benefits","tag-generative-ai","tag-medtech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First AI-generated drug given go-ahead for human trials | DailyAI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/fr\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First AI-generated drug given go-ahead for human trials | DailyAI\" \/>\n<meta property=\"og:description\" content=\"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/fr\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-04T08:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-05T08:09:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eugene van der Watt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene van der Watt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"author\":{\"name\":\"Eugene van der Watt\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\"},\"headline\":\"First AI-generated drug given go-ahead for human trials\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"wordCount\":479,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"keywords\":[\"AI benefits\",\"Generative AI\",\"MedTech\"],\"articleSection\":[\"Industry\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"name\":\"First AI-generated drug given go-ahead for human trials | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"width\":1000,\"height\":563,\"caption\":\"AI generated drug gets human trial approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First AI-generated drug given go-ahead for human trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\",\"name\":\"Eugene van der Watt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"caption\":\"Eugene van der Watt\"},\"description\":\"Eugene comes from an electronic engineering background and loves all things tech. When he takes a break from consuming AI news you'll find him at the snooker table.\",\"sameAs\":[\"www.linkedin.com\\\/in\\\/eugene-van-der-watt-16828119\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/fr\\\/author\\\/eugene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le premier m\u00e9dicament g\u00e9n\u00e9r\u00e9 par l'IA re\u00e7oit le feu vert pour des essais sur l'homme | DailyAI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/fr\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_locale":"fr_FR","og_type":"article","og_title":"First AI-generated drug given go-ahead for human trials | DailyAI","og_description":"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their","og_url":"https:\/\/dailyai.com\/fr\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_site_name":"DailyAI","article_published_time":"2023-07-04T08:09:00+00:00","article_modified_time":"2023-07-05T08:09:37+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","type":"image\/jpeg"}],"author":"Eugene van der Watt","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"\u00c9crit par":"Eugene van der Watt","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"author":{"name":"Eugene van der Watt","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa"},"headline":"First AI-generated drug given go-ahead for human trials","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"wordCount":479,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","keywords":["AI benefits","Generative AI","MedTech"],"articleSection":["Industry"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","url":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","name":"Le premier m\u00e9dicament g\u00e9n\u00e9r\u00e9 par l'IA re\u00e7oit le feu vert pour des essais sur l'homme | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","breadcrumb":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","width":1000,"height":563,"caption":"AI generated drug gets human trial approval"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"First AI-generated drug given go-ahead for human trials"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"Votre dose quotidienne de nouvelles sur l'IA","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa","name":"Eug\u00e8ne van der Watt","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","caption":"Eugene van der Watt"},"description":"Eugene a une formation d'ing\u00e9nieur en \u00e9lectronique et adore tout ce qui touche \u00e0 la technologie. Lorsqu'il fait une pause dans sa consommation d'informations sur l'IA, vous le trouverez \u00e0 la table de snooker.","sameAs":["www.linkedin.com\/in\/eugene-van-der-watt-16828119"],"url":"https:\/\/dailyai.com\/fr\/author\/eugene\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/posts\/2282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/comments?post=2282"}],"version-history":[{"count":1,"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/posts\/2282\/revisions"}],"predecessor-version":[{"id":2284,"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/posts\/2282\/revisions\/2284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/media\/2283"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/media?parent=2282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/categories?post=2282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/fr\/wp-json\/wp\/v2\/tags?post=2282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}